- Home
- ORIC vs BGH Comparison
ORIC vs BGH Comparison
Compare ORIC & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- BGH
- Stock Information
- Founded
- ORIC 2014
- BGH 2012
- Country
- ORIC United States
- BGH United States
- Employees
- ORIC N/A
- BGH N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- BGH Investment Managers
- Sector
- ORIC Health Care
- BGH Finance
- Exchange
- ORIC Nasdaq
- BGH Nasdaq
- Market Cap
- ORIC 362.9M
- BGH 318.8M
- IPO Year
- ORIC 2020
- BGH N/A
- Fundamental
- Price
- ORIC $10.21
- BGH $15.59
- Analyst Decision
- ORIC Strong Buy
- BGH
- Analyst Count
- ORIC 8
- BGH 0
- Target Price
- ORIC $18.83
- BGH N/A
- AVG Volume (30 Days)
- ORIC 1.3M
- BGH 61.5K
- Earning Date
- ORIC 08-11-2025
- BGH 01-01-0001
- Dividend Yield
- ORIC N/A
- BGH 10.06%
- EPS Growth
- ORIC N/A
- BGH N/A
- EPS
- ORIC N/A
- BGH N/A
- Revenue
- ORIC N/A
- BGH N/A
- Revenue This Year
- ORIC N/A
- BGH N/A
- Revenue Next Year
- ORIC N/A
- BGH N/A
- P/E Ratio
- ORIC N/A
- BGH N/A
- Revenue Growth
- ORIC N/A
- BGH N/A
- 52 Week Low
- ORIC $3.90
- BGH $11.92
- 52 Week High
- ORIC $14.67
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- ORIC 63.99
- BGH 72.41
- Support Level
- ORIC $10.05
- BGH $15.01
- Resistance Level
- ORIC $10.99
- BGH $15.51
- Average True Range (ATR)
- ORIC 0.60
- BGH 0.12
- MACD
- ORIC -0.07
- BGH 0.01
- Stochastic Oscillator
- ORIC 54.67
- BGH 78.00
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.